PortfoliosLab logoPortfoliosLab logo
TAYD vs. AYTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TAYD vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Taylor Devices, Inc. (TAYD) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TAYD achieves a -6.24% return, which is significantly higher than AYTU's -11.92% return.


TAYD

1D
3.36%
1M
5.48%
YTD
-6.24%
6M
13.01%
1Y
49.71%
3Y*
40.58%
5Y*
35.50%
10Y*
12.58%

AYTU

1D
1.78%
1M
-8.40%
YTD
-11.92%
6M
2.23%
1Y
14.50%
3Y*
12.70%
5Y*
-53.73%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TAYD vs. AYTU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TAYD
Taylor Devices, Inc.
-6.24%40.46%88.07%55.95%29.91%4.33%-0.38%-13.71%-9.24%-8.40%
AYTU
Aytu BioPharma, Inc.
-11.92%52.94%-40.14%-24.87%-86.00%-77.42%-38.35%22.41%-98.22%-88.85%

Correlation

The correlation between TAYD and AYTU is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Feb 2, 2017

0.06

Fundamentals

EPS

TAYD:

$4.95

AYTU:

-$2.91

PS Ratio

TAYD:

3.10

AYTU:

0.47

Total Revenue (TTM)

TAYD:

$37.08M

AYTU:

$56.60M

Gross Profit (TTM)

TAYD:

$21.95M

AYTU:

$36.14M

EBITDA (TTM)

TAYD:

$13.00M

AYTU:

-$27.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TAYD vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TAYD
TAYD Risk / Return Rank: 6666
Overall Rank
TAYD Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
TAYD Sortino Ratio Rank: 6565
Sortino Ratio Rank
TAYD Omega Ratio Rank: 6666
Omega Ratio Rank
TAYD Calmar Ratio Rank: 6565
Calmar Ratio Rank
TAYD Martin Ratio Rank: 6565
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 5151
Overall Rank
AYTU Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4949
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4949
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5252
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TAYD vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Taylor Devices, Inc. (TAYD) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TAYDAYTUDifference
Sharpe ratioReturn per unit of total volatility

+0.59

Sortino ratioReturn per unit of downside risk

+0.67

Omega ratioGain probability vs. loss probability

1.19

1.10

+0.10

Calmar ratioReturn relative to maximum drawdown

1.11

0.41

+0.70

Martin ratioReturn relative to average drawdown

2.56

0.97

+1.59

TAYD vs. AYTU - Sharpe Ratio Comparison

The current TAYD Sharpe Ratio is 0.86, which is higher than the AYTU Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of TAYD and AYTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TAYDAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.86

0.27

+0.59

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.67

-0.63

+1.30

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

0.13

-0.36

+0.49

Drawdowns

TAYD vs. AYTU - Drawdown Comparison

The maximum TAYD drawdown since its inception was -74.52%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for TAYD and AYTU.


Loading charts...

Drawdown Indicators


TAYDAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-74.52%

-100.00%

+25.48%

Max Drawdown (1Y)

Largest decline over 1 year

-45.06%

-35.47%

-9.59%

Max Drawdown (3Y)

Largest decline over 3 years

-52.65%

-70.24%

+17.59%

Max Drawdown (5Y)

Largest decline over 5 years

-52.65%

-99.12%

+46.47%

Max Drawdown (10Y)

Largest decline over 10 years

-66.49%

Current Drawdown

Current decline from peak

-39.07%

-100.00%

+60.93%

Average Drawdown

Average peak-to-trough decline

-37.29%

-95.15%

+57.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.47%

14.92%

+4.55%

Volatility

TAYD vs. AYTU - Volatility Comparison

The current volatility for Taylor Devices, Inc. (TAYD) is 10.68%, while Aytu BioPharma, Inc. (AYTU) has a volatility of 14.09%. This indicates that TAYD experiences smaller price fluctuations and is considered to be less risky than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TAYDAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.68%

14.09%

-3.41%

Volatility (6M)

Calculated over the trailing 6-month period

45.11%

33.39%

+11.72%

Volatility (1Y)

Calculated over the trailing 1-year period

58.53%

55.06%

+3.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.12%

85.66%

-32.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

46.24%

188.20%

-141.96%

Dividends

TAYD vs. AYTU - Dividend Comparison

Neither TAYD nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TAYD vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between Taylor Devices, Inc. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
12.41M
(TAYD) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TAYD and AYTU have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AYTU has higher volatility (14.09%) compared to TAYD (10.68%). In terms of maximum drawdown, TAYD dropped -74.52% vs AYTU's -100.00%.

TAYD currently has the higher Sharpe Ratio (0.86 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TAYD and AYTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer